• 1
    Brenner H, Gondos A, Pulte D. Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood. 2008;111:25212526.
  • 2
    Kumar SK, Rajkumar SV, Dispenzieri A, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111:25162520.
  • 3
    Catley L, Anderson K. Strategies to improve the outcome of stem cell transplantation in multiple myeloma. Hematol J. 2004;5:923.
  • 4
    Chapko MK, Syrjala KL, Schilter L, Cummings C, Sullivan KM. Chemoradiotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea. Bone Marrow Transplant. 1989;4:181186.
  • 5
    Ahles TA, Tope DM, Furstenberg C, Hann D, Mills L. Psychologic and neuropsychologic impact of autologous bone marrow transplantation. J Clin Oncol. 1996;14:14571462.
  • 6
    Syrjala KL, Artherholt SB, Kurland BF, et al. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. J Clin Oncol. 2011;29:23972404.
  • 7
    Syrjala KL, Dikmen S, Langer SL, Roth-Roemer S, Abrams JR. Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood. 2004;104:33863392.
  • 8
    Andrykowski MA, Schmitt FA, Gregg ME, Brady MJ, Lamb DG, Henslee-Downey PJ. Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer. 1992;70:22882297.
  • 9
    Harder H, Cornelissen JJ, Van Gool AR, Duivenvoorden HJ, Eijkenboom WM, van den Bent MJ. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer. 2002;95:183192.
  • 10
    Molassiotis A, Wilson B, Blair S, Howe T, Cavet J. Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psychooncology. 2011;20:8897.
  • 11
    Potrata B, Cavet J, Blair S, Howe T, Molassiotis A. ‘Like a sieve’: an exploratory study on cognitive impairments in patients with multiple myeloma. Eur J Cancer Care (Engl). 2010;19:721728.
  • 12
    Friedman MA, Fernandez M, Wefel JS, Myszka KA, Champlin RE, Meyers CA. Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design. Arch Clin Neuropsychol. 2009;24:689698.
  • 13
    Jacobs SR, Small BJ, Booth-Jones M, Jacobsen PB, Fields KK. Changes in cognitive functioning in the year after hematopoietic stem cell transplantation. Cancer. 2007;110:15601567.
  • 14
    Beck AT, Brown G, Steer RA. Beck Depression Inventory II Manual. San Antonio, TX: The Psychological Corp.; 1996.
  • 15
    Shah N, Jones D, Mendoza TR, et al. Validation of the M. D. Anderson Symptom Inventory Multiple Myeloma Module. Abstract 6551. In: Proceedings of the 48th Annual Meeting of the American Society of Clinical Oncology; Chicago, IL; June 1–5, 2012; 277.
  • 16
    Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89:16341646.
  • 17
    Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins verbal learning test revised: normative data and analysis of inter-form and test-restest reliability. Clin Neuropsychol. 1998;12:4355.
  • 18
    Heaton RK, Miller SW, Taylor MJ, et al. Revised Comprehensive Norms for an Expanded Halstead–Reitan Battery. Odessa, FL: Psychological Assessment Resources; 2004.
  • 19
    Ruff RM, Light RH, Parker SB, Levin HS. Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol. 1996;11:329338.
  • 20
    Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19:203214.
  • 21
    Wechsler D. Wechsler Adult Intelligence Scale III. San Antonio, TX: The Psychological Corp.; 1997.
  • 22
    Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. ‘Chemobrain’ in breast carcinoma?: a prologue. Cancer. 2004;101:466475.
  • 23
    Chelune GJ, Naugle RI, Luders H, et al. Individual change after epilepsy surgery: practice effects and base-rate information. Neuropsychology. 1993;7:4152.
  • 24
    Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59:1219.
  • 25
    Cleeland CS. The M.D. Anderson Symptom Inventory User Guide. Houston, TX: MD Anderson Cancer Center; 2010.
  • 26
    Wefel JS, Vidrine DJ, Veramonti TL, et al. Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer. 2011;117:190196.
  • 27
    Meyers CA, Byrne KS, Komaki R. Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer. 1995;12:231235.
  • 28
    Meyers CA. Neuropsychological aspects of cancer and cancer treatment. Phys Med Rehabil. 1994;8:229241.
  • 29
    Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010;116:33483356,.
  • 30
    Weis J, Poppelreuter M, Bartsch HH. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: ‘subjective’ complaints and ‘objective’ neuropsychological test results. Psychooncology. 2009;18:775782.
  • 31
    Johnson I, Tabbane K, Dellagi L, Kebir O. Self-perceived cognitive functioning does not correlate with objective measures of cognition in schizophrenia. Compr Psychiatry. 2011;52:688692.
  • 32
    Ganz PA, Kwan L, Castellon SA, et al. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst. 2013;105:791801.
  • 33
    Wechsler D. Wechsler Adult Intelligence Scale–Revised. San Antonio, TX: The Psychological Corp.; 1981.
  • 34
    Reitan RM. Trail Making Test Manual for Administration and Scoring. Tucson, AZ: Reitan Neuropsychology Laboratory; 1992.
  • 35
    Levine AJ, Miller EN, Becker JT, Selnes OA, Cohen BA. Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. Clin Neuropsychol. 2004;18:373384.
  • 36
    Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with 6 equivalent forms. Clin Neuropsychol. 1991;5:125142.
  • 37
    Benton AL, Hamsher K. Multilingual Aphasia Examination. Iowa City, IA: AJA Associates 1983.
  • 38
    Trites R. Neuropsychological Test Manual. Ottawa, ON: Royal Ottawa Hospital; 1977.